An eye on the future for defeating hydrocephalus, ciliary dyskinesia-related hydrocephalus: review article

Amr Ali Hasanain1, Mohamed A R Soliman1,2, Reem Elwy1

  • 1Department of Neurosurgery, Cairo University, Cairo, Egypt.

Insights

Congenital hydrocephalus in newborns is linked to ciliary abnormalities. Research suggests targeting ciliary defects could offer new treatment strategies for this condition.

Area of Science:

  • Pediatric Neurology
  • Genetics
  • Cell Biology

Background:

  • Congenital hydrocephalus affects 1 in 1000 newborns, with a 50% fatality rate if untreated.
  • Current treatments often address symptoms rather than the root cause of cerebrospinal fluid obstruction.
  • There is a need for etiology-specific treatments for hydrocephalus.

Purpose of the Study:

  • To systematically review the literature on the role of ciliary abnormality in congenital hydrocephalus pathogenesis.
  • To explore the potential of targeting ciliary defects in future hydrocephalus treatment research.

Main Methods:

  • Systematic literature review using PubMed.
  • Search terms included 'hydrocephalus,' 'Kartagener syndrome,' 'primary ciliary dyskinesia,' and 'immotile cilia syndrome.'
  • Inclusion criteria: English articles, human patients; Seven studies reporting 12 cases met criteria.

Main Results:

  • Twelve cases of hydrocephalus associated with primary ciliary dyskinesia were identified across seven studies.
  • Patients exhibited diverse clinical presentations, genetic backgrounds, and ciliary defects.
  • Evidence suggests a link between ependymal ciliary abnormality and hydrocephalus, potentially in isolated forms.

Conclusions:

  • Ciliary abnormalities, including primary ciliary dyskinesia, are associated with congenital hydrocephalus.
  • Ependymal cilia, responsible for cerebrospinal fluid movement, may be specifically implicated.
  • Further research into ciliary function and dysfunction is warranted for novel hydrocephalus therapies.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...